Better Therapeutics Total Liabilities

Better Therapeutics (MCAD) currently reports a total liabilities of $21M as of September 2023. That compares with $21M in the prior-year period — down 1.5% year over year. Use the charts on this page to explore Better Therapeutics's total liabilities history and peer comparisons.

Better Therapeutics's total liabilities decreased from $21M to $21M — a 1.5% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Better Therapeutics reported $21M in total liabilities as of September 2023. That compares with $21M in the prior-year period — down 1.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $21M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Better Therapeutics, and consider following MCAD for alerts when major investors trade the stock.